ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

9.00
-0.29
(-3.12%)
Closed July 18 4:00PM
9.00
0.00
( 0.00% )
Pre Market: 4:09AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
9.00
Bid
7.28
Ask
14.40
Volume
-
0.00 Day's Range 0.00
4.52 52 Week Range 12.915
Market Cap
Previous Close
9.00
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
2,169,528
Shares Outstanding
251,924,898
Dividend Yield
-
PE Ratio
-19.05
Earnings Per Share (EPS)
-0.47
Revenue
292.23M
Net Profit
-119.03M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was $9. Over the last year, Maravai LifeSciences shares have traded in a share price range of $ 4.52 to $ 12.915.

Maravai LifeSciences currently has 251,924,898 shares outstanding. The market capitalization of Maravai LifeSciences is $2.27 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -19.05.

MRVI Latest News

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024

SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...

Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report

- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.262.974828375298.749.498.6116654619.04347566CS
41.8626.05042016817.149.496.6726222927.56772128CS
121.3918.26544021027.6111.5556.6721695288.52266972CS
262.7243.31210191086.2811.5555.04524411087.84598707CS
52-3.6-28.571428571412.612.9154.5224690247.98941013CS
156-27.27-75.186104218436.2763.554.52203771218.87583916CS
260-22.11-71.070395371331.1163.554.52191624720.87897451CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HUBCWHub Cyber Security Ltd
$ 0.0345
(94.92%)
62
SERVServe Robotics Inc
$ 4.37
(66.16%)
2.34M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3403
(38.33%)
5.92M
GNLXGenelux Corporation
$ 2.90
(26.09%)
2
CXAICXApp Inc
$ 2.80
(25.56%)
592
KITTNauticus Robotics Inc
$ 0.1012
(-21.49%)
929.41k
SPWRSunPower Corporation
$ 1.25
(-17.22%)
557.03k
MTEMMolecular Templates Inc
$ 1.21
(-15.38%)
1
WAVDWaveDancer Inc
$ 1.71
(-14.93%)
663
AZA2Z Smart Technologies Corporation
$ 0.7623
(-14.33%)
173
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3403
(38.33%)
5.92M
SGDSafe and Green Development Corporation
$ 0.4537
(22.69%)
5.43M
SQQQProShares UltraPro Short QQQ
$ 8.27
(0.49%)
2.81M
SERVServe Robotics Inc
$ 4.37
(66.16%)
2.34M
CRWDCrowdStrike Holdings Inc
$ 298.97
(-12.85%)
1.9M

MRVI Discussion

View Posts
Monksdream Monksdream 5 months ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 5 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 3 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 3 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 3 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

Delayed Upgrade Clock